Centre caps trade margins on non-scheduled cancer drugs at 30%, expects ₹2,500 crore annual savings for patients
viaHindustan Times9 Oct

The government expects to reduce prices of the non-scheduled cancer drugs by up to 70% through the move and help patients save ₹2,500 crore annually.
Khabar Adda curates headlines like this across Top Stories, Entertainment, Bollywood, Hollywood, Crime and Politics from public RSS feeds. This page links out to Hindustan Times's own reporting rather than reproducing it — the excerpt above comes from Hindustan Times's own feed.
Read the full story on Hindustan Times ↗